Louis G. Lange, Director at Audentes Therapeutics, Inc. (BOLD), sold 49,249 shares at $28.35 ($1.4M) on 2018-03-26, disclosed to the SEC on 2018-03-28.
Open-market sale of $1.4M BOLD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.28 | 500 | $14K | 1.0% |
| 2 | $28.32 | 517 | $15K | 1.0% |
| 3 | $28.35 | 18,400 | $522K | 36.6% |
| 4 | $28.38 | 600 | $17K | 1.2% |
| 5 | $29.00 | 11,568 | $335K | 23.5% |
| 6 | $29.27 | 6,600 |
| $193K |
| 13.6% |
| 7 | $29.46 | 500 | $15K | 1.0% |
| 8 | $29.57 | 400 | $12K | 0.8% |
| 9 | $29.57 | 6,700 | $198K | 13.9% |
| 10 | $29.95 | 1,732 | $52K | 3.6% |
| 11 | $29.95 | 1,732 | $52K | 3.6% |
| Total | $28.92 avg | 49,249 | $1.4M | 100% |
| Filing → |
| NAMS | BUY | 2024-02-21 | $95K | — | Filing → |
| BOLD | SELL | 2019-12-27 | $656K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |